TEVA PHARMACEUTICAL INDUSTRIES LTD Insider Trading for February 2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in TEVA PHARMACEUTICAL INDUSTRIES LTD.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in TEVA PHARMACEUTICAL INDUSTRIES LTD for February 2019.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 19 2019 | TEVA | TEVA PHARMACEUTICA ... | Stark David Matthew | Exec. VP Chief Lega ... | Option Exercise | M | 0.00 | 3,926 | 0 | 7,852 | |
| Feb 19 2019 | TEVA | TEVA PHARMACEUTICA ... | Stark David Matthew | Exec. VP Chief Lega ... | Sell | S | 17.74 | 3,926 | 69,647 | 2,974 | 6.9 K to 3 K (-56.90 %) |
| Feb 19 2019 | TEVA | TEVA PHARMACEUTICA ... | Stark David Matthew | Exec. VP Chief Lega ... | Buy | M | 0.00 | 3,926 | 0 | 6,900 | 3 K to 6.9 K (+132.01 %) |
| Feb 19 2019 | TEVA | TEVA PHARMACEUTICA ... | Sabag Mark | EVP, Global Human R ... | Option Exercise | M | 0.00 | 5,710 | 0 | 11,422 | |
| Feb 19 2019 | TEVA | TEVA PHARMACEUTICA ... | Sabag Mark | EVP, Global Human R ... | Buy | M | 0.00 | 5,710 | 0 | 56,608 | 50.9 K to 56.6 K (+11.22 %) |
| Feb 19 2019 | TEVA | TEVA PHARMACEUTICA ... | Fridriksdottir Hafrun | Executive VP, Globa ... | Option Exercise | M | 0.00 | 5,353 | 0 | 10,708 | |
| Feb 19 2019 | TEVA | TEVA PHARMACEUTICA ... | Fridriksdottir Hafrun | Executive VP, Globa ... | Sell | S | 17.67 | 1,841 | 32,529 | 15,338 | 17.2 K to 15.3 K (-10.72 %) |
| Feb 19 2019 | TEVA | TEVA PHARMACEUTICA ... | Fridriksdottir Hafrun | Executive VP, Globa ... | Buy | M | 0.00 | 5,353 | 0 | 17,179 | 11.8 K to 17.2 K (+45.26 %) |
| Feb 19 2019 | TEVA | TEVA PHARMACEUTICA ... | de Notaristefani Carlo | Executive VP Global ... | Option Exercise | M | 0.00 | 9,280 | 0 | 18,560 | |
| Feb 19 2019 | TEVA | TEVA PHARMACEUTICA ... | de Notaristefani Carlo | Executive VP Global ... | Sell | S | 17.67 | 3,192 | 56,399 | 18,209 | 21.4 K to 18.2 K (-14.92 %) |
| Feb 19 2019 | TEVA | TEVA PHARMACEUTICA ... | de Notaristefani Carlo | Executive VP Global ... | Buy | M | 0.00 | 9,280 | 0 | 21,401 | 12.1 K to 21.4 K (+76.56 %) |
| Feb 19 2019 | TEVA | TEVA PHARMACEUTICA ... | Codner Iris Beck | EVP Global Brand&Co ... | Option Exercise | M | 0.00 | 3,212 | 0 | 6,425 | |
| Feb 19 2019 | TEVA | TEVA PHARMACEUTICA ... | Codner Iris Beck | EVP Global Brand&Co ... | Buy | M | 0.00 | 3,212 | 0 | 17,996 | 14.8 K to 18 K (+21.73 %) |
| Feb 14 2019 | TEVA | TEVA PHARMACEUTICA ... | de Notaristefani Carlo | Executive VP Global ... | Option Exercise | A | 0.00 | 1,204 | 0 | 1,204 | |
| Feb 14 2019 | TEVA | TEVA PHARMACEUTICA ... | de Notaristefani Carlo | Executive VP Global ... | Sell | S | 17.88 | 5,041 | 90,108 | 12,121 | 17.2 K to 12.1 K (-29.37 %) |
| Feb 14 2019 | TEVA | TEVA PHARMACEUTICA ... | de Notaristefani Carlo | Executive VP Global ... | Grant | A | 0.00 | 14,432 | 0 | 17,162 | 2.7 K to 17.2 K (+528.64 %) |
| Feb 14 2019 | TEVA | TEVA PHARMACEUTICA ... | Codner Iris Beck | EVP Global Brand&Co ... | Grant | A | 0.00 | 6,494 | 0 | 14,784 | 8.3 K to 14.8 K (+78.34 %) |
| Feb 14 2019 | TEVA | TEVA PHARMACEUTICA ... | Sabag Mark | EVP, Global Human R ... | Grant | A | 0.00 | 9,381 | 0 | 50,898 | 41.5 K to 50.9 K (+22.60 %) |